A new joint report from the Medicines Discovery Catapult and the UK BioIndustry Association (BIA), released today (Thursday 18 January) has revealed insights into the productivity of the UK’s drug discovery community.
Drug discovery
The ‘State of the Discovery Nation 2018’ follows the launch of the Life Sciences Industrial Strategy in the latter part of 2017. It focuses on the small-to-medium enterprise community within drug development and finds that the UK has strong scientific foundations, however, it also reveals that in this time of industry change urgent action is needed to make the R&D model more productive.